Hydrogen Inhalation: Which Flow Rate Should I Choose?
Share
If you’re reading this, you’ve probably reached the point of your curiosity around the health benefits of hydrogen inhalation where you’ve started looking into purchasing your own means of inhaling hydrogen.
Alas… you find yourself faced with an array of hydrogen inhalation “machines”, or more specifically, big chunky electrolysis units offering to break down distilled water into hydrogen and oxygen gases for you to inhale. Marvellous.
Only problem is, you’re given a bewildering choice of flow rates: 900 mL/min, 1500 mL/min, 1800 mL/min, 3000 mL/min and 4200 mL/min. Not only that, but the price differences are enormous. A 4200 mL/min machine can cost several times more than a 900 mL/min model. So, there’s a lot of money riding on the choice.
First, two key principles
Flow rate is not the same as FiH₂
The flow rate leaving the hydrogen generator is not the same as the amount of hydrogen the user actually inhales. Research often refers to FiH₂, which means “Fraction of Inspired Hydrogen”.
Hydrogen reaches a plateau
Hydrogen does not keep building up in the body forever. At a given inspired concentration, blood and tissues rise toward a concentration-dependent steady-state plateau.
FiH₂ simply means the percentage of the gas actually breathed into the lungs that is hydrogen. Roughly speaking, the greater the flow rate, the greater the potential FiH₂ — but only if the user actually captures and inhales enough of the gas.
Hydrogen does not keep building up forever
When you inhale hydrogen at a given concentration, the amount of hydrogen in the blood and tissues does not keep rising indefinitely.
Instead, it rises toward a plateau.
That plateau is sometimes described as “saturation”, but this needs to be understood carefully. It does not mean the body has one fixed maximum hydrogen limit, where anything above that is wasted regardless of the machine used. It means that, for a given inspired hydrogen concentration, the blood and tissues move toward a steady-state level.
In a small human study using a controlled 3–4% hydrogen gas mixture, blood hydrogen gradually rose and reached a plateau after around 20 minutes of inhalation.1
When the hydrogen was stopped, arterial hydrogen levels fell rapidly, while venous hydrogen declined more slowly, suggesting that hydrogen had entered tissues and was then gradually returning to the blood.
Animal tissue studies add another layer to this. In one rat study using continuous 3% hydrogen inhalation, hydrogen was measured directly in different organs using real-time microsensors. Brain, liver, kidney and fat reached their plateau within roughly 6–9 minutes, while thigh muscle took closer to 20 minutes.2
Why the plateau happens
The reason this plateau happens is largely physical. Hydrogen enters the blood through the alveoli in the lungs because there is initially a strong concentration gradient: hydrogen is higher in the lungs and lower in the blood.
Hydrogen reaches the lungs.
Gas enters the airways through the cannula or mask.
Hydrogen crosses the alveoli.
It moves from the lungs into the blood because of the concentration gradient.
Hydrogen dissolves in plasma.
Unlike oxygen, hydrogen does not appear to have a dedicated carrier system like haemoglobin. It is mainly transported as dissolved molecular hydrogen in the plasma.4
Hydrogen moves into tissues.
As hydrogen dissolves into blood and tissues, the gradient becomes smaller until a steady-state plateau is reached.
This is important because it does not mean higher-flow machines are irrelevant.
If a higher-flow machine produces a higher actual FiH₂ — in other words, a higher percentage of hydrogen in the breath reaching the lungs — then the hydrogen pressure gradient between the lungs and blood may be higher. In theory, that can produce a higher blood and tissue hydrogen plateau.
This has been shown in animal work comparing different hydrogen concentrations. Higher inhaled hydrogen concentrations produced higher measured hydrogen concentrations inside tissues. So the plateau is not a single universal ceiling. It is concentration dependent.3
Higher hydrogen exposure does not automatically mean proportionally greater benefit
So, yes, higher flow could potentially increase hydrogen exposure if it increases the actual FiH₂.
But higher hydrogen exposure does not automatically mean proportionally greater biological effect. The research suggests that higher concentrations can raise measured hydrogen inside tissues, but it does not yet prove a simple “more hydrogen in, more benefit out” relationship.
A higher-flow machine may increase delivery capacity and help compensate for real-world losses such as dilution with room air, mask or cannula inefficiency, mouth breathing, leaks and higher breathing volume. But there is no clear evidence that benefits scale in a straight line with machine flow rate.
The practical question: can 1800 mL/min reach the low single-digit research range?
The key question then becomes: what flow rate is likely to achieve the low single-digit FiH₂ conditions commonly used in research literature?
To keep the calculation understandable, we are using air inhaled per minute. This simply means the total amount of air a person breathes into their lungs over one minute while resting. A calm adult might inhale around 6–8 litres per minute, although this varies depending on body size, breathing depth, stress, exercise and health status.
Using a simple model, it is entirely plausible that a continuous 1800 mL/min oxyhydrogen machine, such as the JH-1800 Prime, could sit in or around this range under calm resting conditions.
Starting assumption:
1800 mL/min oxyhydrogen output = approximately 1200 mL/min hydrogen + 600 mL/min oxygen.
If the user inhales for around 30% of the minute:
1200 mL/min hydrogen × 30% = 360 mL H₂/min available during inhalation.
| Air inhaled per minute | H₂ needed to reach 4% FiH₂ | H₂ available from 1800 mL/min machine during inhale | Estimated FiH₂ | Meets 4% FiH₂? |
|---|---|---|---|---|
| 6 L/min | 240 mL/min | 360 mL/min | 6.0% | Yes |
| 7 L/min | 280 mL/min | 360 mL/min | 5.1% | Yes |
| 8 L/min | 320 mL/min | 360 mL/min | 4.5% | Yes |
| 9 L/min | 360 mL/min | 360 mL/min | 4.0% | Yes, just |
What this table suggests
- An 1800 mL/min oxyhydrogen machine produces approximately 1200 mL/min of hydrogen.
- If inhalation occupies around 30% of the breathing cycle, around 360 mL/min of hydrogen is available during inhalation.
- Under this simplified model, 1800 mL/min can theoretically reach around 4% FiH₂ when resting inhalation volume is up to roughly 9 L/min.
- Actual FiH₂ will vary depending on breathing depth, mask fit, cannula use, leakage, mouth breathing and whether gas is retained between breaths.
So which flow rate makes sense?
This is why we see the 1800 mL/min model as a strong practical middle ground.
The case for 1800 mL/min is not that it is the highest possible output, or that higher-flow machines have no value. The case is that it appears capable, under simple resting assumptions, of reaching the low single-digit inspired hydrogen range used in a meaningful part of the research literature.
That matters because this is where the cost-benefit trade-off comes in. Moving from a lower-flow machine to 1800 mL/min gives a clear increase in hydrogen delivery capacity. But moving beyond 1800 mL/min into 3000 mL/min or 4200 mL/min often comes with a much larger increase in price, while the evidence does not show that biological benefits rise proportionally with that extra flow.
So, for many home users, 1800 mL/min may represent the most sensible balance: strong enough to plausibly reach the low single-digit FiH₂ range under ordinary resting conditions, but without the major price jump attached to the highest-output models.
The 3000 mL/min and 4200 mL/min models may still make sense for users who want more delivery headroom, who are concerned about real-world losses, or who want a higher-output machine. But more flow should be understood as more delivery capacity — not as a guarantee of proportionally greater benefit.
Higher flow gives greater hydrogen delivery capacity. It may increase FiH₂ and tissue exposure. But the extra cost of higher-output machines should be weighed against the fact that benefits have not been shown to increase in direct proportion to flow rate.
References
- Ono, H., Nishijima, Y., Adachi, N. et al. A basic study on molecular hydrogen inhalation in acute cerebral ischemia patients for safety check with physiological parameters and measurement of blood H₂ level. Medical Gas Research 2, 21 (2012). https://doi.org/10.1186/2045-9912-2-21
- Yamamoto, R., Homma, K., Suzuki, S. et al. Hydrogen gas distribution in organs after inhalation: Real-time monitoring of tissue hydrogen concentration in rat. Scientific Reports 9, 1255 (2019). https://doi.org/10.1038/s41598-018-38180-4
- Liu BY, Xue JL, Gu QQ, Zhao M, Zhang MY, Wang MY, Wang Y, Qin SC. In vivo microelectrode monitoring of real-time hydrogen concentration in different tissues of rats after inhaling hydrogen gas. Medical Gas Research. 2022;12(3):107–112. doi: 10.4103/2045-9912.330694.
- Sano M, Ichihara G, Katsumata Y, Hiraide T, Hirai A, Momoi M, Tamura T, Ohata S, Kobayashi E. Pharmacokinetics of a single inhalation of hydrogen gas in pigs. PLOS ONE. 2020;15(6):e0234626. doi: 10.1371/journal.pone.0234626.